Category: AWG

Post

The Antimicrobials Working Group Announces Appointment of Christine Ann Miller as Board Chair

WASHINGTON, Jan. 17, 2023 /PRNewswire/ — The Antimicrobials Working Group (AWG), an industry-led coalition of antimicrobial companies, announced today the appointment of Christine Ann Miller, President and Chief Executive Officer of Melinta Therapeutics, as Board Chair of AWG effective immediately. Ms. Miller replaces Ted Schroeder, Chief Executive Officer of Nabriva Therapeutics, who has completed his term as Chair. “I...

Post

Acurx Pharmaceuticals Joins the Antimicrobials Working Group

WASHINGTON, Aug. 5, 2021 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the addition of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (Acurx) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG’s membership to 13 antimicrobial drug companies. Acurx is a clinical stage biopharmaceutical company developing a...

Post

Crestone Joins Antimicrobials Working Group

WASHINGTON, June 8, 2021 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. (Crestone) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG’s membership to 12 antimicrobial drug companies. Crestone is a clinical stage biopharmaceutical company focused...

Post

UTILITY Therapeutics Joins Antimicrobials Working Group

WASHINGTON, February 17, 2021 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG’s membership to 13 antimicrobial drug companies. UTILITY is focused on developing and commercializing...

February 17, 2021February 17, 2021by In AWG
Post

Antimicrobials Working Group Announces Updates to Leadership Team

WASHINGTON, Jan. 27, 2021 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the appointment of a new Chairperson, Ciara Kennedy, Ph.D., President and Chief Executive Officer of Amplyx Pharmaceuticals, Inc. Dr. Kennedy replaces Evan Loh, M.D., Chief Executive Officer of Paratek Pharmaceuticals, Inc., who has completed his two-year term as Chairman of AWG. Dr....

January 27, 2021January 27, 2021by In AWG
Post

Antimicrobials Working Group Announces Updates to Leadership Team

WASHINGTON, Jan. 17, 2019 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the appointment of a new Chairman, Evan Loh, M.D., President, Chief Operating Officer and Chief Medical Officer of Paratek Pharmaceuticals, Inc. Dr. Loh replaces Jeffrey Stein, Ph.D., President and Chief Executive Officer of Cidara Therapeutics, whose two-year term as Chairman of AWG has expired. Dr. Stein...

Post

VenatoRx Pharmaceuticals Joins Antimicrobials Working Group

WASHINGTON, Jan. 3, 2019 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the addition of VenatoRx Pharmaceuticals, Inc. to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG’s membership to 15 antimicrobial drug companies. VenatoRx is a world leader in antibacterial and antiviral drug...

Post

Qpex Biopharma Joins Antimicrobials Working Group

WASHINGTON, Oct. 30, 2018 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the addition of Qpex Biopharma, Inc. (Qpex) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. Qpex is developing a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and...

Post

Summit Therapeutics Joins Antimicrobials Working Group

WASHINGTON, July 30, 2018 /PRNewswire/ — The Antimicrobials Working Group (AWG) announced today the addition of Summit Therapeutics plc (NASDAQ: SMMT; AIM: SUMM) (Summit) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. Summit is an international biopharmaceutical company developing new mechanism antibiotics for C. difficile infection and gonorrhea and is...

Post

Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2018

WASHINGTON, June 6, 2018 /PRNewswire/ — The Antimicrobials Working Group (AWG) today announced that 13 of its member companies will present data from their clinical and research programs at the American Society for Microbiology’s ASM Microbe 2018 meeting to be held June 7-11 in Atlanta, GA. ASM Microbe showcases the best microbial sciences in the world and provides a one-of-a-kind...